16-18 November, 2018 Amsterdam
![]() |
![]() |
![]() |
![]() |
P-003 | COGNITIVE IMPAIRMENT IS RELATED TO A REDUCED COUNT OF B-LYMPHOCYTES IN ELDERLY PATIENTS DIAGNOSED WITH NON-SMALL CELL LUNG CANCER | Teresa Soria Comes | ![]() |
![]() |
|||
P-005 | FEASIBILITY OF ERIBULIN MESYLATE IN ELDERLY PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER: A POST HOC SUBGROUP ANALYSIS OF THE ESEMPIO STUDY | Sandro Barni | ![]() |
![]() |
|||
P-008 | THE TOLERABILITY OF AROMATASE INHIBITORS IN ELDERLY PATIENTS WITH EARLY STAGE BREAST CANCER: A RETROSPECTIVE STUDY | Bareia Chaudhry | ![]() |
![]() |
|||
P-009 | BARRIERS AND FACILITATORS FOR OMITTING PARTS OF LOCOREGIONAL TREATMENT IN OLDER PATIENTS WITH EARLY STAGE BREAST CANCER FROM THE PATIENTS PERSPECTIVE | Anna de Boer | ![]() |
![]() |
|||
PS-009 | Integrated Geriatric Oncology Care for Older People at Rockingham General Hospital | Heather Lane | ![]() |
![]() |
|||
PS-010 | SIOG Advanced course on geriatric oncology Impact on my daily practice | Hélose Rouvière | ![]() |
![]() |
|||
P-011 | USE OF TAXANE-CONTAINING ADJUVANT CHEMOTHERAPY REGIMENS AMONG OLDER WOMEN WITH OPERABLE EARLY BREAST CANCER: DATA FROM A POPULATION-BASED COHORT WITHIN THE NATIONAL AUDIT OF BREAST CANCER IN OLDER PATIENTS (NABCOP) | Melissa Gannon | ![]() |
![]() |
|||
P-013 | PRIMARY AND ADJUVANT TREATMENT FOR UNILATERAL DUCTAL CARCINOMA IN-SITU (DCIS) IN WOMEN AGED OVER 70 YEARS IN ENGLAND AND WALES: A POPULATION BASED COHORT STUDY WITHIN THE NATIONAL AUDIT OF BREAST CANCER IN OLDER PATIENTS (NABCOP) | Yasmin Jauhari | ![]() |
![]() |
|||
P-014 | DECISION MAKING NEEDS OF OLDER ADULT WOMEN CONSIDERING CHEMOTHERAPY FOR EARLY STAGE BREAST CANCER | Meghan Karuturi | ![]() |
![]() |
|||
P-018 | FOLLOW-UP REQUIREMENTS BASED ON THE RISK IN ELDERLY PATIENTS WITH BREAST CANCER | Carmen Salvador-Coloma | ![]() |
![]() |
|||
P-019 | PHARMACOKINETIC-GUIDED DOCETAXEL IN ELDERLY BREAST CANCER PATIENTS RECEIVING ADJUVANT DOCETAXEL AND CYCLOPHOSPHAMIDE | Christine Walko | ![]() |
![]() |
|||
P-020 | FINAL RESULTS OF THE PHASE II TRIAL EVALUATING THE EFFICACY AND SAFETY OF REGORAFENIB MONOTHERAPY IN PATIENTS (PTS) AGED = 70 YEARS (YRS) WITH PRETREATED METASTATIC COLORECTAL ADENOCARCINOMA (MCRC) FFCD 1404 - REGOLD | Thomas Aparicio | ![]() |
![]() |
|||
PS-020 | REDESIGN OF THE COMPREHENSIVE GERIATRIC ASSESSMENT OF A COHORT STUDY | Rebello Mirella | ![]() |
![]() |
|||
P-024 | FRAILTY IN COLORECTAL CARCINOMA PATIENTS WHO RECEIVED SURGERY INVESTIGATED | Marlies Dijk | ![]() |
![]() |
|||
P-026 | DELAYS IN TREATMENT FOR OLDER COLORECTAL CANCER PATIENTS IN AN NCI-DESIGNATED CANCER CENTER, SERVING A HISPANIC MAJORITY COMMUNITY | Sukeshi Arora | ![]() |
![]() |
|||
P-030 | DISCRIMINATIVE VALUE OF FRAILTY SCREENING IN COLORECTAL CANCER PATIENTS SCHEDULED FOR SURGERY | Tanja Argillander | ![]() |
![]() |
|||
P-031 | A RETROSPECTIVE REVIEW OF TREATMENT PATTERNS, TOXICITY RATES AND SURVIVAL OUTCOMES IN WOMEN OVER THE AGE OF 65 ACROSS TWO UK CANCER CENTRES | Lucy Dumas | ![]() |
![]() |
|||
P-037 | IMPACT OF PALLIATIVE RADIOTHERAPY IN ELDERLY PATIENTS WITH HEAD AND NECK CANCER | Cláudia Sousa | ![]() |
![]() |
|||
P-039 | GERIATRIC ASSESSMENT AND ONE-YEAR MORTALITY IN OLDER PATIENTS WITH CANCER IN THE HEAD AND NECK REGION, A COHORT STUDY. | Floor van Deudekom | ![]() |
![]() |
|||
P-041 | USE OF GAMMA-KNIFE RADIOSURGERY IN CEREBRAL METASTASIS OF NON-SMALL CELL LUNG CANCER: OLD PATIENTS ARE NOT ALL THE SAME | Manuela Bernardo | ![]() |
![]() |
|||
P-044 | POPULATION-BASED PATTERNS OF TREATMENT AND SURVIVAL FOR PATIENTS AGED 65-74 YEARS AND =75 YEARS WITH STAGE I AND II NON-SMALL CELL LUNG CANCER IN THE NETHERLANDS | Elisabeth Driessen | ![]() |
![]() |
|||
P-045 | A prognostic model for non-lung-cancer death in old patients treated with stereotactic body radiotherapy for early-stage non-small cell lung cancer | Yukinori Matsuo | ![]() |
![]() |
|||
P-046 | Efficacy and Toxicity Profile of Immune Checkpoint Inhibitors in Routine Clinical Practice of Older Adults Treated for Advanced-Stage Non-Small Cell Lung Cancer | Eugene Muchnik | ![]() |
![]() |
|||
P-050 | Immune Risk Phenotype (IRP) in patients &8805; 70 years treated for a metastatic cancer | Mathilde Cabart | ![]() |
![]() |
|||
P-056 | IADL SCALE ITEMS ARE MORE PREDICTIVE OF EFFICACY RESULTS THAN OTHER SCALES IN METASTASIC CASTRATION RESISTANT PROTATE CANCER (MCRPC) PATIENTS TREATED WITH CABAZITAXEL IN A WEEKLY SCHEDULE | miguel climent | ![]() |
![]() |
|||
P-058 | MANAGEMENT OF METASTATIC PROSTATE CANCER IN THE ELDERLY: COMPARISON OF OLD AND VERY OLD PATIENTS | Filipa Ferreira | ![]() |
![]() |
|||
P-059 | INITIAL MANAGEMENT OF LOCALISED PROSTATE CANCER IN THE ELDERLY: AN INTERNATIONAL DATA REVIEW | Mark Prentice | ![]() |
![]() |
|||
P-060 | EBRT FOR PROSTATE CANCER: TOLLERANCE IN ELDERLY. | Roberto Rossi | ![]() |
![]() |
|||
P-064 | THE GAH SCALE (GERIATRIC ASSESSMENT IN HEMATOLOGY) CORRELATES WELL WITH A COMPREHENSIVE GERIATRIC ASSESSMENT IN OLDER PATIENTS WITH HEMATOLOGICAL MALIGNANCIES INCLUDING LYMPHOMA | Raul Cordoba | ![]() |
![]() |
|||
P-066 | PATIENT GENERAL CONDITION AND THE OVERALL SURVIVAL OF OLDER ADULTS WITH MYELODYSPLASTIC SYNDROMES AND RELATED DISEASES (CHRONIC MYELOMONOCYTIC LEUKEMIA AND ACUTE MYELOID LEUKEMIA) | FERNANDO RAMOS | ![]() |
![]() |
|||
P-067 | CLINICAL OUTCOME OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA: AN ANALYSIS OF A TERTIARY REFERRAL CENTER OVER TWO DECADES | Jana Ihlow | ![]() |
![]() |
|||
P-068 | AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS OVER 65 YEARS OLD: A SINGLE CENTER EXPERIENCE | INES MARTINEZ ALFONZO | ![]() |
![]() |
|||
P-069 | PLACE OF DEATH IN HAEMATOLOGICAL MALIGNANCY IN A COHORT OF OLDER PATIENTS THAT HAD BEEN ADMITTED TO A COMPREHENSIVE CANCER CENTRE: VARIATIONS BY DISEASE AND SIX-MONTH MORTALITY. | Deborah Moreno-Alonso | ![]() |
![]() |
|||
P-081 | THE EFFECT OF POLYPHARMACY ON CLINICAL OUTCOMES IN OLDER ADULTS WITH CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS | MOSTAFA MOHAMED | ![]() |
![]() |
|||
P-082 | METASTATIC BREAST CANCER IN GERIATRIC PATIENTS: ILLNESS PERCEPTION AND QUALITY OF LIFE | Isabel Domingues | ![]() |
![]() |
|||
P-088 | PREDICTORS IN ELDERLY ASIAN PATIENTS FOR CHEMOTHERAPY RELATED TOXICITIES (PEACT) STUDY | Angela Pang | ![]() |
![]() |
|||
P-089 | A NOVEL MOBILE HEALTH APPLICATION TO DELIVER GERIATRIC ASSESSMENT-DRIVEN INTERVENTIONS FOR OLDER ADULTS WITH CANCER: A MIXED-METHOD STUDY | Kah Poh Loh | ![]() |
![]() |
|||
P-092 | ELDERLY FUNCTIONAL INDEX (ELFI) FOR ASSESSMENT OF FUNCTIONING IN PATIENTS WITH CANCER: HOW DOES IT MEASURE UP? | Wee Kheng Soo | ![]() |
![]() |
|||
P-093 | THE UNDERREPORTING OF CLINICAL TRIAL DATA OF OLDER PATIENTS WITH CANCER: A REVIEW OF ONCOLOGIC THERAPEUTIC PHASE-3 CLINICAL TRIAL LITERATURE. | Armin Shahrokni | ![]() |
![]() |
|||
P-094 | A RANDOMIZED STUDY INVESTIGATING THE IMPACT OF COMPREHENSIVE GERIATRIC ASSESSMENT IN PATIENTS WITH NON-SMALL CELL LUNG CANCER TREATED WITH STEREOTACTIC BODY RADIOTHERAPY - FINAL QUALITY OF LIFE RESULTS | Stefan Jeppesen | ![]() |
![]() |
|||
P-095 | GERO-REPAIR JOINS GERO-PROTECTION IN CANCER PREVENTION | Eduardo Lasalvia-Prisco | ![]() |
![]() |
|||
P-098 | IMMUNE CHECKPOINT INHIBITORS IN OLDER ADULTS WITH MELANOMA OR CUTANEOUS MALIGNANCIES: THE WILMOT CANCER INSTITUTE EXPERIENCE | William Archibald | ![]() |
![]() |
|||
P-099 | OUTCOME OF IMMUNOTHERAPY IN THE ELDERLY. REAL-WORLD EXPERIENCE | Mónica Cejuela | ![]() |
![]() |
|||
P-101 | CHECKPOINT INHIBITORS EFFICACY IN PATIENTS OLDER THAN 75 YEARS: A META-ANALYSIS | Thierry Landre | ![]() |
![]() |
|||
P-102 | QUALITY OF PRESCRIBING PRACTICES OF DOACS IN ADULTS AGE 65 AND OLDER WITH ATRIAL FIBRILLATION: RESULTS FROM A LARGE ACADEMIC CENTER. | Shakira Grant | ![]() |
![]() |
|||
P-104 | INCIDENCE OF DYSLIPIDEMIA AND DYSGLYCEMIA IN PROSTATE CANCER INDIVIDUALS DURING ANDROGEN DEPRIVATION THERAPY IN ONCOGERIATRY CLINIC OF IMIP | DIOGO SALES | ![]() |
![]() |
|||
P-106 | ARE RADIATION ONCOLOGISTS READY FOR THE AGEING TSUNAMI? DEFINING AN INTERNATIONAL CURRICULUM FOR GERIATRIC RADIATION ONCOLOGY | LUCINDA MORRIS | ![]() |
![]() |
|||
P-107 | HYBRID MRI-RADIOTHERAPY AS NEW FRONTIER IN THE TREATMENT OF FRAIL ELDERLY PATIENTS WITH CANCER: A FIRST INSIGHT IN A PROMISING FIELD OF APPLICATION | Emanuele Rocco Villani | ![]() |
![]() |
|||
P-111 | THATS EXPENSIVE- HOLY TOLEDO FINANCIAL TOXICITY: A QUALITATIVE ANALYSIS OF COST CONVERSATIONS BETWEEN OLDER ADULTS WITH CANCER, THEIR CAREGIVERS AND COMMUNITY ONCOLOGISTS FROM THE UNIVERSITY OF ROCHESTER NCI COMMUNITY ONCOLOGY PROGRAM | Asad Arastu | ![]() |
![]() |
|||
P-112 | THE ASSOCIATION OF FRAILTY WITH COMMUNICATION ABOUT AGE-RELATED CONCERNS IN OLDER PATIENTS WITH ADVANCED CANCER: A SUBGROUP ANALYSIS FROM A UNIVERSITY OF ROCHESTER NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM (UR NCORP) CLUSTER RANDOMIZED TRIAL | Nikesha Gilmore | ![]() |
![]() |
|||
P-115 | IMPACT OF AWARENESS OF PHYSICAL PERFORMANCE AND FUNCTION ON CONVERSATIONS BETWEEN OLDER PATIENTS WITH ADVANCED CANCER, CAREGIVERS AND ONCOLOGISTS: A UNIVERSITY OF ROCHESTER NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM (UR NCORP) CLUSTER RANDOMIZED STUDY | LIANLIAN LEI | ![]() |
![]() |
|||
P-117 | PROGNOSTIC UNDERSTANDING AND DISCORDANCE IN OLDER PATIENTS, CAREGIVERS, AND ONCOLOGISTS IN ADVANCED CANCER: BASELINE DATA FROM A UNIVERSITY OF ROCHESTER NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM TRIAL | Kah Poh (Melissa) Loh | ![]() |
![]() |
|||
P-123 | ASSOCIATION OF FINANCIAL TOXICITY WITH ANXIETY, EMOTIONAL DISTRESS AND QUALITY OF LIFE IN CAREGIVERS OF OLDER ADULTS WITH ADVANCED CANCER: ANALYSIS OF 414 CAREGIVERS FROM 31 PRACTICES IN THE UNIVERSITY OF ROCHESTER NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM | Asad Arastu | ![]() |
![]() |
|||
P-129 | ONCONGERIATRIC EVALUATION OF UROLOGICAL TUMOURS PRIOR TO THERAPEUTIC DECISION | EVA BUSTAMANTE | ![]() |
![]() |
|||
P-130 | RECOMMENDATIONS FOR A COMPREHENSIVE GERIATRIC ASSESSMENT OF OLDER CANCER PATIENTS . CONSENSUS OF THE GERIATRIC ONCOLOGY GROUP OF THE CATALAN SOCIETY OF GERIATRICS AND GERONTOLOGY. | EVA BUSTAMANTE | ![]() |
![]() |
|||
P-132 | ASSESSMENT AND MANAGEMENT OF OLDER PATIENTS WITH METASTATIC BREAST CANCER (MBC) AMONG COMMUNITY ONCOLOGISTS IN THE UNITED STATES | Efrat Dotan | ![]() |
![]() |
|||
P-133 | PROVIDING GERIATRIC ASSESSMENT (GA) REPORT TO PROVIDERS OF OLDER ADULTS WITH CANCER AND MALNUTRITION IMPROVES CONVERSATIONS ABOUT NUTRITION: A UNIVERSITY OF ROCHESTER NCORP CLUSTER-RANDOMIZED INTERVENTION TRIAL. | Richard Dunne | ![]() |
![]() |
|||
P-136 | FRAILTY SCREENING AND RELATIONSHIP WITH IMPAIRMENTS ON GERIATRIC ASSESSMENT | Jenifer Gomez Mediavilla | ![]() |
![]() |
|||
P-138 | ONCOLOGY TREATMENT PLANNING FOR PATIENTS AGED 65 WITH A MODIFIED SCALE OF OVERALL GERIATRIC ASSESSMENT (PATIENT SCORE CARD) | Radoslaw Jadczak | ![]() |
![]() |
|||
P-140 | SKELETAL RELATED EVENTS IN SENIOR ADULTS WITH PROSTATE CANCER | Sonia Jimenez Mola | ![]() |
![]() |
|||
P-141 | CHARACTERISTICS OF ELDERLY PATIENTS WITH CANCER AND HIP FRACTURE | Sonia Jimenez Mola | ![]() |
![]() |
|||
P-143 | INTEGERATE: IS INTEGRATED GERIATRIC ASSESSMENT AND TREATMENT EFFECTIVE FOR OLDER ADULTS WITH CANCER RECEIVING CHEMOTHERAPY? | Soo Wee Kheng | ![]() |
![]() |
|||
P-146 | IMPACT OF FRAILTY ACCORDING TO A GERIATRIC ASSESSMENT, ON PROGNOSIS IN ELDERLY LUNG CANCER PATIENTS. | Borja López de San Vicente | ![]() |
![]() |
|||
P-147 | GERIATRIC ASSESSMENT IN GLIOBLASTOMA PATIENTS: A FEASIBLE PROCESS FOR MAINSTREAM NEURO ONCOLOGY CANCER CARE | Cressida Lorimer | ![]() |
![]() |
|||
P-152 | FACTORS ASSOCIATED WITH THE NEED FOR INTERVENTIONS BASED ON A CGA DONE IN AN ASIAN GERIATRIC ONCOLOGY SETTING | Angela Pang | ![]() |
![]() |
|||
P-154 | PEOPLE ARE SHOCKED AND THEN THEY START USING IT: ONCOLOGY PROVIDERS PERCEIVED BARRIERS TO IMPLEMENTATION OF THE GERIATRIC ASSESSMENT | Erika Ramsdale | ![]() |
![]() |
|||
P-159 | UTILITY OF THE GERIATRIC ASSESSMENT IN THE CARE PROCESS OF A COHORT OF SENIOR ADULTS WITH CANCER, SUBSIDIARIES OF CHEMOTHERAPY, AT THE UNIVERSITY HOSPITAL | Lucia Richter | ![]() |
![]() |
|||
P-161 | FRAILTY AND FUNCTIONAL IMPAIRMENT: PREDICTORS OF IN-HOSPITAL MORTALITY IN ELDERLY PATIENTS WITH CANCER | Joseanne Maria Teixeira | ![]() |
![]() |
|||
P-164 | A PILOT STUDY TO EXAMINE THE FEASIBILITY OF PERSONALIZING TREATMENT OPTIONS OF ELDERLY BREAST CANCER PATIENTS THROUGH INDIVIDUAL RISK PROFILING | Dacita Suen | ![]() |
![]() |
|||
P-167 | EVALUATION OF THE INCIDENCE AND RELEVANCE OF MEDICATION INTERACTIONS FOR PATIENTS ABOVE 65 YEARS OF AGE, WHO UNDERGO STEM CELL TRANSPLANTATION | Nidia Torres Pena | ![]() |
![]() |
|||
P-168 | RELEVANCE OF LOW VITAMIN D LEVELS ON OLDER PATIENTS UNDERGOING BONE MARROW TRANSPLANT (BMT). | Nidia Torres Pena | ![]() |
![]() |
|||
P-171 | GERSOC: A CLUSTER RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFECTIVENESS OF A GERIATRIC SCREENING IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED OVARIAN CANCER | Neeltje Johanna van Soolingen | ![]() |
![]() |
|||
P-181 | RESULTS OF A GLOBAL ASSESSMENT OF THE ELDERLY PATIENT WITH CANCER IN A NURSING VALORATION | HELIS TELLERIA SORET | ![]() |
![]() |
|||
P-182 | HOW MUCH DO ELDERLY PHYSICIANS KNOW ABOUT GERIATRIC ONCOLOGY? | Jia Chong | ![]() |
![]() |
|||
P-185 | CANCER CARE SHARED DECISION-MAKING FOR OLDER ADULTS: A SYSTEMATIC REVIEW | Holly Holmes | ![]() |
![]() |
|||
P-186 | NEEDS ASSESSMENT OF LEARNERS TRAINING IN GERIATRIC ONCOLOGY | ronald maggiore | ![]() |
![]() |
|||
P-188 | ADVANCED COURSE OF GERIATRIC ONCOLOGY IN TREVISO (SIOG). A CHANGE IN MY MIND. | Carlos Onoro | ![]() |
![]() |
|||
P-193 | E-MENTORING IN GERIATRIC ONCOLOGY | Kuang Teck Tay | ![]() |
![]() |
|||
P-194 | USING NEAR-PEER AND PEER MENTORING IN GERIATRIC ONCOLOGY | Kuang Teck Tay | ![]() |
![]() |
|||
P-195 | DOWNSTREAM CONSEQUENCES OF ABNORMAL COGNITIVE SCREENING IN OLDER ADULTS SEEN PRE-TREATMENT IN A GERIATRIC ONCOLOGY CLINIC | Uzair Malik | ![]() |
![]() |
|||
P-196 | PREVALENCE OF AND FACTORS ASSOCIATED WITH UPFRONT CHEMOTHERAPY DOSE MODIFICATION IN OLDER ADULTS WITH ADVANCED CANCER RECEIVING PALLIATIVE TREATMENT | MOSTAFA MOHAMED | ![]() |
![]() |
|||
P-198 | OPTIMIZING PSYCHOSOCIAL CARE OF OLDER ADULTS WITH CANCER: AN EARLY ASSESSMENT AND INTERVENTION MODEL | Lora Rhodes | ![]() |
![]() |
16-18 November, 2018 Amsterdam
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|